The correlation between SMARCB1 expression and response to neoadjuvant chemotherapy in osteosarcoma
(A) Comparison of SMARCB1 expression in specimens with and without neoadjuvant chemotherapy. (B) Comparison of SMARCB1 expression in specimens showing good and poor response to neoadjuvant chemotherapy. (C) The correlation between SMARCB1 expression and tumor necrosis rates in osteosarcoma specimens. (D) The comparisons of SMARCB1 expression between specimens with/without neoadjuvant chemotherapy and good/poor chemotherapeutic response in specimens obtained from patients with primary localized osteosarcoma. The numbers (n) in Figure 3A,B,D reflect the numbers of specimens of osteosarcoma blocks.